Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/Amlodipine vs Amlodipine in Black Patients with Stage II Hypertension
NCT00353912Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of valsartan in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoint: Change from baseline in Mean Sitting Systolic Blood Pressure at 8 weeks. Started Jun 2006; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00353912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00353912.